References

Multiple sclerosis: current knowledge and future outlook

10.1159/000360528 · 2014 · External reference

Multiple sclerosis pathology

10.1101/cshperspect.a028936 · 2018 · External reference

The immunopathophysiology of multiple sclerosis

10.1016/j.ncl.2010.12.009 · 2011 · External reference

Multiple sclerosis: the role of cytokines in pathogenesis and in therapies

10.3390/ijms131013438 · 2012 · External reference

Stage-specific role of interferon-gamma in experimental autoimmune encephalomyelitis and multiple sclerosis

10.3389/fimmu.2015.00492 · 2015 · External reference

MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis

10.1093/brain/aww084 · 2016 · External reference

Astrocytes are active players in cerebral innate immunity

10.1016/j.it.2007.01.005 · 2007 · External reference

Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity

10.1016/j.jns.2008.06.029 · 2008 · External reference

The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis

10.1007/s00401-019-01980-7 · 2019 · External reference

editors. Control of autoimmune CNS inflammation by astrocytes

2015 · External reference

Astrocytes in multiple sclerosis and experimental autoimmune encephalomyelitis: Star-shaped cells illuminating the darkness of CNS autoimmunity

10.1016/j.bbi.2019.05.029 · 2019 · External reference

The role of astrocytes in multiple sclerosis pathogenesis

10.1016/j.nrleng.2017.07.018 · 2020 · External reference

GDNF synthesis, signaling, and retrograde transport in motor neurons

10.1007/s00441-020-03287-6 · 2020 · External reference

GDNF, a neuron-derived factor upregulated in glial cells during disease

10.3390/jcm9020456 · 2020 · External reference

Regulation of astrocyte functions in multiple sclerosis

10.1101/cshperspect.a029009 · 2019 · External reference

The function, composition and analysis of cerebrospinal fluid in companion animals: Part I–Function and composition

10.1016/j.tvjl.2005.07.021 · 2006 · External reference

Inflammatory intrathecal profiles and cortical damage in multiple sclerosis

10.1002/ana.25197 · 2018 · External reference

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

10.1172/jci5150 · 1999 · External reference

Cerebrospinal fluid cytokine expression profile in multiple sclerosis and chronic inflammatory demyelinating polyneuropathy

10.1080/08820139.2017.1405978 · 2018 · External reference

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

10.1016/s1474-4422(17)30470-2 · 2018 · External reference

The role of astrocytes in multiple sclerosis progression

10.3389/fneur.2015.00180 · 2015 · External reference

Mouse models of multiple sclerosis: lost in translation?

10.2174/1381612821666150316122706 · 2015 · External reference

Layer-specific morphological and molecular differences in neocortical astrocytes and their dependence on neuronal layers

10.1038/s41467-018-03940-3 · 2018 · External reference

The emerging nature of astrocyte diversity

10.1146/annurev-neuro-070918-050443 · 2019 · External reference

Astrocytes, from brain glue to communication elements: the revolution continues

10.1038/nrn1722 · 2005 · External reference

The astrocyte in multiple sclerosis revisited

10.1002/glia.22443 · 2013 · External reference

Signaling pathways in reactive astrocytes, a genetic perspective

10.1007/s12035-011-8163-7 · 2011 · External reference

Heterogeneity of reactive astrocytes

10.1016/j.neulet.2013.12.030 · 2014 · External reference

Reactive astrocytes: production, function, and therapeutic potential

10.1016/j.immuni.2017.06.006 · 2017 · External reference

Neurotoxic reactive astrocytes are induced by activated microglia

10.1038/nature21029 · 2017 · External reference

Astrocyte heterogeneity: impact to brain aging and disease

10.3389/fnagi.2019.00059 · 2019 · External reference

Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis

10.1016/j.jns.2009.08.057 · 2009 · External reference

Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-β 1a, and high doses of immunoglobul

10.1177/1352458506070146 · 2007 · External reference

Functional regeneration of sensory axons into the adult spinal cord

10.1038/35002084 · 2000 · External reference

Trophic factor distribution predicts functional recovery in parkinsonian monkeys

10.1002/ana.20549 · 2005 · External reference

GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo

10.1016/0896-6273(95)90024-1 · 1995 · External reference

VEGF in the nervous system

10.4161/org.6.2.11687 · 2010 · External reference

Vascular endothelial growth factor as a predictive and prognostic biomarker for multiple sclerosis

10.1159/000525600 · 2022 · External reference

Extrinsic factors driving oligodendrocyte lineage cell progression in CNS development and injury

10.1007/s11064-020-02967-7 · 2020 · External reference

Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis

10.1186/s40478-014-0084-z · 2014 · External reference

Vascular endothelial growth factors A and C are induced in the SVZ following neonatal hypoxia–ischemia and exert different effects on neonatal glial progenitors

10.1007/s12975-012-0213-6 · 2013 · External reference

New findings and old controversies in the research of multiple sclerosis and its model experimental autoimmune encephalomyelitis

10.1586/eci.13.21 · 2013 · External reference

Emerging roles of astrocytes in neural circuit development

10.1038/nrn3484 · 2013 · External reference

Astrocyte–endothelial interactions at the blood–brain barrier

10.1038/nrn1824 · 2006 · External reference